The Burden of Disease and the Changing Task of Medicine by Jones, David Shumway et al.
 
The Burden of Disease and the Changing Task of Medicine
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Jones, David S., Scott H. Podolsky, and Jeremy A. Greene. 2012.
“The Burden of Disease and the Changing Task of Medicine.”
New England Journal of Medicine 366 (25) (June 21): 2333–2338.
doi:10.1056/nejmp1113569.
http://dx.doi.org/10.1056/NEJMp1113569.
Published Version doi:10.1056/nejmp1113569
Accessed February 19, 2015 3:31:06 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11880309
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Open Access Policy Articles, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#OAP200th Anniversary Article 
The Burden of Disease and the Changing Task of Medicine 
David S. Jones, M.D., Ph.D., Scott H. Podolsky, M.D., and Jeremy A. Greene, M.D., 
Ph.D. 
 
 
At first glance, the inaugural 1812 issue of the New England Journal of Medicine 
and Surgery seems reassuringly familiar: a review of angina pectoris, articles on infant 
diarrhea and burns. The apparent similarity to today’s Journal, however, obscures a 
fundamental discontinuity. Disease has changed since 1812.  People have different 
diseases, doctors hold different ideas about those diseases, and diseases carry different 
meanings in society.  To understand the material and conceptual transformations of 
disease over the past 200 years, one must explore the inextricably social nature of 
disease. 
Disease is always generated, experienced, defined, and ameliorated within a 
social world.  Patients need notions of disease that explicate their suffering.  Doctors need 
theories of etiology and pathophysiology that account for the burden of disease and 
inform therapeutic practice.  Policymakers need realistic understandings of determinants 
of disease and medicine’s impact in order to design systems that foster health.  The 
history of disease offers crucial insights into the intersections of these interests and the 
ways they can inform medical practice and health policy. 
 
Epidemiologic transitions In addition to angina, diarrhea, and burns, early Journal issues examined gunshot 
wounds, spina bifida, Tetralogy of Fallot, diabetes, hernia, epilepsy, osteomyelitis, 
syphilis, cancer, croup, asthma, rabies, and urethral stones.  Although some case reports 
describe patients who might walk into urgent care today, others are nearly 
unrecognizable.  Apoplexy, a syndrome of fainting spells that might mean stroke, seizure, 
or syncope today, was understood to arise from a “nervous sympathy” by which the 
stomach influenced the head (1812d).  Doctors agreed that even a near miss by a 
cannonball -- without contact -- could shatter bones, blind people, or even kill them 
(1812f).  Reports of spontaneous combustion, especially of “brandy-drinking men and 
women,” received serious, if skeptical, consideration (1812g).  And physicians were 
obsessed with fevers — puerperal, petechial, catarrhal, even an outbreak of “spotted 
fever” in which some patients were neither spotted nor febrile (1812e).  The bill of 
mortality from 1811 (see extract) contains both the familiar and the exotic (1812h).  
Consumption, diarrhea, and pneumonia dominated the mortality data, but teething, 
worms, and drinking cold water apparently killed as well. 
A century later, the infections that filled the Journal had been redefined according 
to specific microbial causes.  The Journal ran reviews of tuberculosis (1912b), gonorrhea 
(1912e), and syphilis (1912i).  Diphtheria, measles, pneumonia, scarlet fever, and typhoid 
made frequent cameos, and Massachusetts still maintained a leper colony on Penikese 
Island (1912d).  Tropical infections also fascinated authors, whether worms in 
immigrants or outbreaks of plague, yellow fever, and malaria in the nation’s new tropical 
empire. Doctors in 1912 did have some reasons to celebrate.  By any account, the previous 
year had been “the healthiest of which there is any record” (1912a). Nearly every Journal 
issue that year mentioned another centenarian, and coverage of the “overwhelming 
success” of U.S. athletes at the Stockholm Olympics celebrated American racial vigor 
(1912f).  One editorial, describing progress made since the Journal’s early years, 
rhapsodized about what another century of medical discovery might bring: “Perhaps in 
1993, when all the preventable diseases have been eradicated, when the nature and cure 
of cancer have been discovered, and when eugenics has superseded evolution in the 
elimination of the unfit, our successors will look back at these pages with an even greater 
measure of superiority” (1912c). 
Such paeans to progress, however, were accompanied by fear of the morbid 
consequences of modernization.  One article described a new problem, “automobile 
knee,” and decried the prevalence of “persons of extremely indolent habits of life” who 
no longer walked more “than the few steps that are needed from the chamber to the 
elevator, from the elevator to the dining-room, or lounging-room, and then to the 
automobile”(1912j).  Long-standing concern about epilepsy, alcoholism, and feeble-
mindedness took on new relevance in a society increasingly preoccupied by fears of race 
suicide and the promise of eugenics (1912g, 1912h).  Doctors struggled with cancers, 
eclampsia, impotence, heart disease (chiefly infectious or valvular, rather than 
atherosclerotic), and arthritis. 
During the 20th century, heart disease, cancer, and other chronic conditions 
assumed more dominant roles (see graph), though outbreaks of infectious disease, from 
eastern equine encephalitis (1938) and kuru (1957) to legionnaires’ disease (1977), AIDS (1981), and multidrug-resistant tuberculosis (1993), necessitated ongoing vigilance 
against microbes.  New concerns also came to medical attention, from the terrifying 
consequences of thermonuclear war (1962) to the indolent but devastating effects of 
environmental pollution (1966) and climate change (1989).  Optimism about prospects 
for future health persisted but remained tempered by concern about the pathologies of 
civilization.  An obesity epidemic, feared in 1912, has come to pass.  Our previously 
steady increase in life expectancy has stalled and may even reverse (2005). 
 
Definitions and consequences 
The material and conceptual dynamism of disease poses challenges: how do we 
define disease meaningfully, and how do we measure our burden of disease and set health 
policy priorities?  These are deceptively simple questions.  Merriam-Webster’s Medical 
Dictionary’s definition of disease as “an impairment of the normal state of the living 
animal or plant body” begs the question: What is normal?  What is impaired?  We cannot 
answer by reference to biology alone: the line between normal and pathological requires 
value judgments.  As physicians know, not every symptom constitutes a disease.  Nor, as 
anthropologists have shown, is it feasible simply to contrast “disease,” as diagnosed by 
doctors, with “illness,” as experienced by patients.
*  As contemporary disputes over 
alcoholism, chronic fatigue syndrome, and attention-deficit disorder make clear, 
physicians are never the sole arbiters of disease. 
Any responsible attempt to define disease must account for the phenomenon’s 
complexity.  A disease has characteristic signs and symptoms, afflicts particular groups 
of people, and follows a characteristic course.  Doctors name a disease and work to identify its cause and develop ways to prevent and treat it.  But patients also ascribe 
meaning to their suffering and assign responsibility for what went wrong.
1  And diseases 
have utility, with concrete consequences for patients, doctors, and their institutions.
2  
They mediate patients’ claims to the sick role and adjudicate access to health care 
resources.  Disease definitions structure the practice of health care, its reimbursement 
systems, and our debates about health priorities and policies.  These political and 
economic stakes explain the fierce debates that erupt over definitions of such conditions 
as chronic fatigue syndrome and Gulf War syndrome.  Disease is a deeply social process.  
Its distribution lays bear society’s structures of wealth and power.  The responses it elicits 
illuminate strongly held values.
3 
The complexities and consequences of disease extend to its measurement.  Even 
after a disease has been clearly defined, measuring its frequency, intensity, and relevance 
is not simple.  Since the 17th century, polities have compiled causes of death into annual 
bills of mortality.  Successive generations of demographers and epidemiologists have 
transformed such statistics into age-adjusted measures of disease-specific mortality and 
developed measures of morbidity and disease’s impact on people’s ability to lead 
meaningful, productive lives (including disability- and quality-adjusted life-years).  But 
such measures reduce the complex experience of disease to a single coefficient.   
A population’s disease status can also be gauged by lists of common diagnoses at 
clinics or hospitals, but no single measure definitively characterizes a population’s 
burden of disease.  Choosing among metrics is as much about values and priorities as 
about science, and it directly affects health policy.  Whereas advocates of clinical and 
research funding for cardiovascular disease might use mortality data to support their claims, mental health advocates can cite morbidity measures in seeking greater resources.  
Data on causes of childhood mortality would justify certain priorities; analyses of health 
care spending would justify others.  An ideal, sophisticated health policy would integrate 
all measures to form a holistic map of the burden of disease, but in practice competing 
interests use different representations of disease burden to recommend particular policies. 
 
Accounting for the burden of disease 
Regardless of the metric chosen, any map of the burden of disease exposes 
disparities within and among populations.   Two aspects of the burden of disease have 
remained particularly vexing: changes over time in the prevailing diseases and the 
persistence of health inequalities. 
By examining the many new diseases that have appeared over the past two 
centuries, historians have categorized the ways in which diseases emerge.  New causes 
(e.g., severe acute respiratory syndrome, motor vehicle accidents, radiation poisoning), 
new behaviors (cigarette smoking, intravenous drug use), and even the consequences of 
new therapies (insulin transforming the course and manifestations of diabetes) can 
produce new diseases.  Changing environmental and social conditions can increase the 
prevalence of once-obscure ailments (myocardial infarction, lung cancer, kuru and “mad 
cow” disease).  New diagnostic technologies and therapeutic capacity can unmask 
previously unrecognized conditions (hypertension).  New diagnostic criteria can expand a 
disease’s boundaries (enzyme leak myocardial infarction, major depression).  Changing 
social mores can redefine what is or is not a disease (homosexuality, alcoholism, 
masturbation).  New diseases can emerge as the result of conscious advocacy by interested parties (chronic fatigue syndrome, sick building syndrome).  HIV–AIDS alone 
demonstrates many of these modes of emergence.  The emergence, recognition, and 
impact of disease are never just a bio-scientific process; the advent of a new disease 
always involves social, economic, and political processes that shape its epidemiology and 
influence our understanding and response. 
The interaction between the biologic and the social is equally apparent in 
diseases’ decline.  Cannonball injuries, a frequent cause of concern in 1812, disappeared 
from the Journal, only to be replaced by a new and more terrible litany of war-related 
injuries.  Neurasthenia, a widespread phenomenon of depleted nervous energy in the late 
19th century, has disappeared, but traces of it remained recognizable in other diagnoses 
throughout the past century. In some cases, a disease’s decline clearly resulted from 
medical action.  Immunizations eradicated smallpox and may someday eradicate polio.  
Genetic screening has led to dramatic reductions in Tay–Sachs disease, thalassemia, and 
familial dysautonomia (2009).  But often the potential for eradication has been 
incompletely realized — witness the continued prevalence of AIDS and tuberculosis in 
low-income countries and of atherosclerotic heart disease globally. 
Even as prevailing diseases have changed, health disparities have endured.  
Inequalities in health status have always existed, regardless of how health has been 
measured or populations defined.  When Europeans arrived in the Americas, they 
witnessed stark disparities in the fates of European, American, and African populations.
  
Experiencing the ravages of 19th-century industrialization, physicians grew familiar with 
health disparities between rich and poor.  Health inequalities remain ubiquitous, not just among races and ethnic groups, but also according to geography, sex, educational level, 
occupation, income, and other gradients of wealth and power.
4 
The persistence of health inequalities challenges our scientific knowledge and 
political will.  Can we explain them and alleviate them?  Genetic variations don’t explain 
why mortality rates double as you cross Boston Harbor from Back Bay to Charlestown or 
walk up Fifth Avenue from midtown Manhattan into Harlem.  Nor do they explain why 
Asian-American women in Bergen County, New Jersey, live 50% longer than Native 
American men in South Dakota.
5  Although we know something about the relationships 
among poverty, stress, allostatic load, and the hypothalamic–pituitary–adrenal axis, 
doctors and epidemiologists need more precise models that fill in the steps between social 
exposure, disease, and death. 
Accounting for the history of disease also requires us to examine why some 
disparities in disease are seen as proof of a natural order while others are considered 
evidence of injustice.  The 4.3-year life-expectancy gap between blacks and whites in the 
U.S. provokes outrage, but the 4.9-year gap between men and women does not.  It’s 
tempting to assume that differences between the sexes are natural and those between 
races aren’t.  But a 19th-century Journal reader might be skeptical of this explanation: 
men then lived at least as long as women.  The survival advantage of women that 
appeared in the 20th century owed as much to changes in childbearing, improvements in 
obstetrical practice, and a new epidemic of heart disease disproportionally affecting men 
as to differences between X and Y chromosomes.  Health and disease disparities are 
contingent outcomes of the ways society structures the lives and risks of individuals. Recognition of the contingency of health inequalities should make them a target 
for intervention, yet the opposite has frequently happened: the ill health of impoverished 
or marginalized groups has been used against them — as evidence of their inferiority or 
as an argument that they’re unworthy of assistance.  Such sentiments drove tragic 
government policies toward African-Americans and Native Americans in the late 19th 
and early 20th centuries.  They may underlie current policies that would limit health care 
access for mentally ill, impoverished, or immigrant populations. 
 
The roles of medicine 
Medical practice and health policy rely on the assumption that the solution to the 
problem of disease is to be found in physicians and their therapies.  Physicians tend to 
credit biomedical science with 20th-century improvements in health and longevity.  The 
history, however, is complex and contested. 
For example, after Robert Koch’s 1882 discovery of Mycobacterium tuberculosis  
and the advent of antibiotics in the 1940s, physicians claimed responsibility for the 
decline of tuberculosis in Europe and North America.  But closer examination revealed 
that this decline had begun before Koch’s discovery and had largely run its course before 
effective antibiotics became available.  Medicine’s critics instead credited improvements 
in the standard of living, especially diet.  A similar debate has emerged about coronary 
artery disease.  Heart disease, like tuberculosis, followed a century-long epidemic wave, 
peaking in the United States in the 1960s before beginning 50 years of decline.  
Researchers have struggled to determine how much credit to give to health care or risk-
factor reduction (2007).  The decline narrative and debates, however, have been complicated by countries, notably the Russian Federation and China, where coronary 
disease has recently increased, and by signs of a plateau and possible reversal of decline 
in the United States, Australia, and Western Europe (2005).
  The stakes of this debate are 
substantial, with implications for allocation of contested health care resources. 
Is there a best health policy?  Our goal should be an integrated policy under which 
health care and public health programs together fully eclipse the disease burden (see 
diagram).  But the details depend on how we conceptualize and measure disease.  And 
disease is never static.  Just as organisms evolve to keep up with changing environmental 
conditions (the “Red Queen Effect”), medicine struggles to keep up with the changing 
burden of disease.  Since therapeutic innovation takes time, the burden shifts even as 
solutions appear.  By the time antibiotics and vaccines began combating infectious 
diseases, mortality had shifted toward heart disease, cancer, and stroke.  Great progress 
has been made against these challenges, but the burden of disease will surely shift again.  
We already face increasing neuropsychiatric disease for which satisfying treatments don’t 
yet exist. 
In many respects, our medical systems are best suited for diseases of the past, not 
those of the present or future.  We must continue to adapt health systems and health 
policy as the burden of disease evolves.  But we must also do more.  Diseases can never 
be reduced to molecular pathways, mere technical problems requiring treatments or 
cures.  Disease is a complex domain of human experience, involving explanation, 
expectation, and meaning.  Doctors must acknowledge this complexity and formulate 
theories, practices, and systems that fully address the breadth and subtlety of disease. 
  
From the Department of Global Health and Social Medicine, Harvard Medical School 
(D.S.J., S.H.P., J.A.G.); the Center for the History of Medicine, Countway Library of 
Medicine (S.H.P.); and the Division of Pharmacoepidemiology and Pharmacoeconomics, 
Brigham and Women’s Hospital (J.A.G.) — all in Boston; and the Department of the 
History of Science, Harvard University, Cambridge, MA (D.S.J., J.A.G.). 
 
Disclosure forms provided by the authors are available with the full text of this article at 
NEJM.org. 
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[extract] 
Causes of Death in 1811.  Abstract of the Bill of Mortality for the Town of Boston.  
From 1812h. 
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The Shifting Burden of Disease.  
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Medicine, Public Health, and the Eclipse of Disease (Panel A), and the Red Queen Effect 
(Panel B). 
  
 